亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Evaluation of the hypothetical risk of sudden cardiac death in obstructive HCM patients treated with mavacamten using the HCM Risk-SCD score

医学 心脏病学 内科学 肥厚性心肌病 危险分层 心源性猝死 心室流出道梗阻 心室流出道 心力衰竭 猝死 前瞻性队列研究 心肌病 观察研究 射血分数 心电图 试验预测值 药物治疗 心脏病 窦性心律 弗雷明翰风险评分 队列
作者
M Silveira Ramos,R Esculudes Dos Santos Ferrao Gomes,R Lima,D Correia,S Maltes,Tânia Laranjeira,G Cunha,C Aguiar,B M Rocha
出处
期刊:European Journal of Heart Failure [Elsevier BV]
卷期号:28 (Supplement_2)
标识
DOI:10.1093/ejhf/xuag193.1195
摘要

Abstract Background Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden cardiac death (SCD). Risk stratification may be performed using the HCM Risk-SCD score, which has been validated in cohorts of patients treated with first-line medical therapy (beta-blockers or calcium channel blockers). Mavacamten, a novel selective cardiac myosin inhibitor, has been shown to reduce left ventricular outflow tract obstruction (LVOTO) and to promote reverse remodeling. Its influence on the estimated HCM Risk-SCD score, which incorporates echocardiographic parameters that may change with therapy, remains unclear. Objective To assess hypothetical changes in the estimated HCM Risk-SCD score in patients with obstructive HCM treated with mavacamten. Methods We conducted a prospective observational study including all patients with HCM treated with mavacamten who had been on a stable dose for at least 3 months. Clinical data and transthoracic echocardiograms were reviewed to collect maximal wall thickness (MWT), left atrial diameter (LAD), and maximal LVOTO. The HCM Risk-SCD score was calculated using the ESC online tool. Comparisons were assessed using the Wilcoxon signed-rank test. Results Forty patients were included [58% male; median age 62 (61–71) years and follow-up 7 (3–12) months]. Echocardiographic parameters improved significantly in comparison to baseline, with reductions in maximal LVOTO [84 (68–129) vs. 5 (0–39) mmHg; p<0.001], MWT [18 (16–20) vs. 15 (14–18) mm; p<0.001], and LAD [43 (39–47) vs. 40 (36–44) mm; p=0.008]. Mavacamten was associated with a significant reduction in the HCM Risk-SCD score, decreasing from 2.4 (1.7–4.7) to 1.5 (1.1–2.6) %, corresponding to an absolute change of −0.9 (−2.0 to −0.5) % and a relative reduction of −40 (−52 to −26) % (p<0.001) (central figure). At baseline, four patients had a high estimated 5-year SCD risk (>6%) – all of whom had an implantable cardioverter-defibrillator. During follow-up, three were reclassified in the low-risk category (<4%), while one remained in the high-risk group. No patient transitioned into a higher risk category after treatment. Per-patient decomposition of the HCM Risk-SCD reduction showed that most of the improvement was driven by changes in LVOTO (median −0.52%), with smaller contributions from MWT (−0.29%) and LAD (−0.08%). Conclusion Mavacamten was associated with a significant reduction in the estimated HCM Risk-SCD score. Whether this improvement translates into a true reduction in the 5-year SCD incidence remains uncertain. External validation in large multicenter cohorts with long-term follow-up is required to determine whether the decrease in the hypothetical risk corresponds to reduced mortality.Central figureFor image description, please refer to the figure legend and surrounding text.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
顺利秋天完成签到,获得积分10
13秒前
甜甜的黑猫完成签到,获得积分10
18秒前
33秒前
等待若魔完成签到,获得积分10
36秒前
研友_VZG7GZ的应助被落润晓采纳,获得10
39秒前
46秒前
俭朴迎荷完成签到,获得积分10
51秒前
落润晓发布了新的文献求助10
51秒前
rongrongrong完成签到,获得积分10
1分钟前
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
繁荣的玲完成签到,获得积分10
1分钟前
玩命的智宸完成签到,获得积分10
1分钟前
斯文败类的应助被落润晓采纳,获得10
1分钟前
水北完成签到,获得积分10
1分钟前
1分钟前
2分钟前
火星上的笑寒完成签到,获得积分10
2分钟前
传奇3的应助被落润晓采纳,获得10
2分钟前
我与我周旋久完成签到 ,获得积分10
2分钟前
2分钟前
传统完成签到,获得积分10
2分钟前
落润晓发布了新的文献求助10
2分钟前
苹果元灵完成签到,获得积分10
2分钟前
长情的小蕾完成签到,获得积分10
2分钟前
2分钟前
李爱国的应助被towind采纳,获得10
2分钟前
yjdong完成签到,获得积分10
2分钟前
2分钟前
2分钟前
nanwang完成签到,获得积分10
2分钟前
2分钟前
落润晓发布了新的文献求助10
2分钟前
3分钟前
哪块小饼干完成签到,获得积分10
3分钟前
dddj完成签到,获得积分10
3分钟前
奔跑的应助被科研通管家采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158789
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748389
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551987
邀请新用户注册赠送积分活动 2471354